B

BioCryst Pharmaceuticals
D

BCRX

8.55500
USD
0.00
(0.00%)
مغلق
حجم التداول
85,943
الربح لكل سهم
0
العائد الربحي
-
P/E
-33
حجم السوق
1,790,136,094
أصول ذات صلة
ALNY
ALNY
1.29
(0.39%)
329.01 USD
BNTX
BNTX
0.720
(0.63%)
115.290 USD
C
CRSP
-1.350
(-2.04%)
64.760 USD
E
EDIT
-0.11000
(-3.38%)
3.14000 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
INCY
INCY
-0.300
(-0.43%)
70.180 USD
MRNA
MRNA
0.125
(0.37%)
34.145 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
R
RGEN
-0.200
(-0.16%)
121.670 USD
VRTX
VRTX
-2.89
(-0.61%)
469.58 USD
المزيد
الأخبار المقالات

العنوان: BioCryst Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.